Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 111.87
+1.57 (1.42%)
Jan 29, 2026, 3:56 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 1.07 billion as of January 29, 2026. Its market cap has increased by 701.60% in one year.
Market Cap
1.07B
Enterprise Value
990.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
111.87
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 1.07B, an increase of 1,912.66%. That is a compound annual growth rate of 82.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 1.09B | 26.61% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | 53.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 622.97M |
| NervGen Pharma | 497.81M |
| Satellos Bioscience | 248.58M |
| Helix BioPharma | 166.50M |
| ME Therapeutics Holdings | 90.15M |
| Medicenna Therapeutics | 73.41M |
| Sharp Therapeutics | 72.18M |
| NurExone Biologic | 60.76M |